Pharmaceutical Manufacturer

DIA annual meeting highlights potential of pharmacists

Therapure Biopharma Inc. launched with a pledge to provide Canadian biotech companies specializing in biological protein therapeutics with better access to the global market.

Angioedema is a self-limiting, nonpitting edema that occurs in the skin and mucous membranes.

NDMAC wants Canadians to use the federal election as an opportunity to stress the need for amendments to the Food and Drugs Act.

Santhera Pharmaceuticals is introducing Catena for the symptomatic management of patients with Friedreich's ataxia, which is a rare, progressive neuromuscular disease.

Nadine Saby, president and CEO of CACDS, issues a wake up call about the future of pharmacy in Canada.